药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Carfentanil
Hexoprenaline
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Levosalbutamol.
Carfentanil
Protokylol
The risk or severity of adverse effects can be increased when Protokylol is combined with Levosalbutamol.
Carfentanil
Brofaromine
The risk or severity of adverse effects can be increased when Brofaromine is combined with Levosalbutamol.
Carfentanil
Harmaline
The risk or severity of adverse effects can be increased when Harmaline is combined with Levosalbutamol.
Carfentanil
Caroxazone
The risk or severity of adverse effects can be increased when Caroxazone is combined with Levosalbutamol.
Carfentanil
Safrazine
The risk or severity of adverse effects can be increased when Safrazine is combined with Levosalbutamol.
Carfentanil
Pivhydrazine
The risk or severity of adverse effects can be increased when Pivhydrazine is combined with Levosalbutamol.
Carfentanil
Phenoxypropazine
The risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Levosalbutamol.
Carfentanil
Pheniprazine
The risk or severity of adverse effects can be increased when Pheniprazine is combined with Levosalbutamol.
Carfentanil
Octamoxin
The risk or severity of adverse effects can be increased when Octamoxin is combined with Levosalbutamol.
Carfentanil
Mebanazine
The risk or severity of adverse effects can be increased when Mebanazine is combined with Levosalbutamol.
Carfentanil
Benmoxin
The risk or severity of adverse effects can be increased when Benmoxin is combined with Levosalbutamol.
Carfentanil
Hydracarbazine
The risk or severity of adverse effects can be increased when Hydracarbazine is combined with Levosalbutamol.
Carfentanil
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Levosalbutamol.
Carfentanil
Nialamide
The risk or severity of adverse effects can be increased when Nialamide is combined with Levosalbutamol.
Carfentanil
Iproniazid
The risk or severity of adverse effects can be increased when Iproniazid is combined with Levosalbutamol.
Carfentanil
Clorgiline
The risk or severity of adverse effects can be increased when Clorgiline is combined with Levosalbutamol.
Carfentanil
Pargyline
The risk or severity of adverse effects can be increased when Pargyline is combined with Levosalbutamol.
Carfentanil
Azosemide
The risk or severity of hypokalemia can be increased when Levosalbutamol is combined with Azosemide.
Carfentanil
Piretanide
The risk or severity of hypokalemia can be increased when Levosalbutamol is combined with Piretanide.